Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33,940,151
-
Total 13F shares
-
21,299,571
-
Share change
-
-443,093
-
Total reported value
-
$423,671,614
-
Price per share
-
$19.90
-
Number of holders
-
67
-
Value change
-
-$4,482,122
-
Number of buys
-
35
-
Number of sells
-
28
Institutional Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q4 2020
As of 31 Dec 2020,
TransMedics Group, Inc. - Common Stock (TMDX) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,299,571 shares.
The largest 10 holders included
FMR LLC, ABRAMS CAPITAL MANAGEMENT, L.P., BlackRock Inc., CREDIT SUISSE AG/, Sandhill Capital Partners LLC, VANGUARD GROUP INC, MACQUARIE GROUP LTD, KPCB XIII Associates, LLC, EMERALD ADVISERS, LLC, and Bellevue Group AG.
This page lists
67
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.